ARTICLE
25 September 2021

Grant Alert: COVID-19 TechVoucher Program

MA
Moore Australia

Contributor

Moore Australia logo
Moore Australia part of a global network of offices, providing auditing and financial reporting services, advising local, national and international clients in the public and private sectors. Moore Australia generates annual revenues in the region of $80m. Moore Australia is part of the Moore Global network and has 14 offices with over 450 people nationwide. Moore Australia has extensive experience in state and local government, biotechnology, energy mining and renewables, health and aged care, education, manufacturing, not for profit, property and construction, retail and tourism and hospitality and has a strong presence in the following service lines: Asia Desk, Audit & Assurance, Business Advisory, Taxation, Corporate Finance, Governance and Risk Advisory.
The program provides support funding for technology-rich startups, scaleups or SMEs to accelerate commercialisation.
Australia Technology
To print this article, all you need is to be registered or login on Mondaq.com.

The COVID-19 TechVoucher program provides support funding for technology-rich startups, scaleups or SMEs to collaborate with Publicly Funded Research Organisations (PFRO) to accelerate the commercialisation of innovative R&D products and services that address ongoing disruptions.Eligible businesses The program is available to incorporated entities that are start-ups, scaleups or SMEs and have:

Eligible businesses

The program is available to incorporated entities that are start-ups, scaleups or SMEs and have:

  • an ABN registered in NSW and are based in NSW
  • fewer than 200 employees
  • operated for at least 12 months, based on date of ABN registration
  • at least $150,000 in sales revenue or operating expenditure within the last 12 months
  • at least 75% Australian ownership (and not more than 50% owned by another business)
  • propose a technology-based product or service that addresses the impacts of COVID-19
  • provide evidence of the ability to co-invest at least 50 per cent of eligible project budget
  • demonstrate capability and capacity to complete the TechVoucher project within six months (Stream 1) or 12 months (Stream 2)
  • be engaged with an eligible PFRO for R& D collaboration and have obtained a quote
  • confirmation that the business holds the rights to commercialise the IP from the project.

Eligible activities

Activities funded by the program include:

  • access to research facilities and equipment such as electron microscopes, medical imaging, and other PRFO delivery partner facilities
  • product or process design, such as engineering or technical design expertise to determine prototype structure, function or materials
  • validating or demonstrating technical capabilities of a product, process or technology including clinical trials and in-market validation
  • funding toxicology studies on materials that could be incorporated into a new product
  • testing and certification for supply of products
  • enhancing existing product capabilities or enabling entry to international markets.

Funding

Funding is available in two streams depending on the size of the R& D project and is matched by the government up to a certain amount.

Total projected budget Intended project duration Matched government contribution
Stream 1: Smaller R & D projects $30,000 to $50,000 Up to six months Maximum $25,000
Stream 2: Larger R & D projects $50,001 to $100,000+ Up to 12 months Maximum $50,000

A TechVoucher will fund up to 50 per cent of all invoices issued by a PFRO partner to the maximum value of the voucher for each stream.

Funding will be provided for approved projects until the available funding is exhausted or the final deadline for applications. Status Applications close on 29 October 2021.

Status

Applications close on 29 October 2021.

This article is issued as general commentary - please contact us about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More